Drug Discovery: Overview
Combination Therapies and Personalized Medicine
Treatment Resistant Cancers
Targeted Cancer Therapies
Prodrugs
Prescription, Nonprescription and Orphan Drugs
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
D L van der Velden1,2, L R Hoes1,2,3, H van der Wijngaart2,3,4
1Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
在使用非标签药物治疗的34%罕见癌症变异患者中,药物重新发现协议发现了临床益处. 这项精确瘤试验加速了新的癌症治疗见解, 并分享了未来治疗决策的知识.
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: